These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 12478278

  • 1. HIV: conformational camouflage.
    Jardetzky T.
    Nature; 2002 Dec 12; 420(6916):623-4. PubMed ID: 12478278
    [No Abstract] [Full Text] [Related]

  • 2. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites.
    Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S, Steenbeke TD, Venturi M, Chaiken I, Fung M, Katinger H, Parren PW, Robinson J, Van Ryk D, Wang L, Burton DR, Freire E, Wyatt R, Sodroski J, Hendrickson WA, Arthos J.
    Nature; 2002 Dec 12; 420(6916):678-82. PubMed ID: 12478295
    [Abstract] [Full Text] [Related]

  • 3. AIDS/HIV. Converging on an HIV vaccine.
    Korber B, Gnanakaran S.
    Science; 2011 Sep 16; 333(6049):1589-90. PubMed ID: 21921189
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP, Geyer SJ, Hanson CV, Hendry RM, Milman G.
    AIDS; 1994 Feb 16; 8(2):169-81. PubMed ID: 7519019
    [Abstract] [Full Text] [Related]

  • 5. Structural definition of a conserved neutralization epitope on HIV-1 gp120.
    Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH, Yang X, Zhang MY, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, Nabel GJ, Kwong PD.
    Nature; 2007 Feb 15; 445(7129):732-7. PubMed ID: 17301785
    [Abstract] [Full Text] [Related]

  • 6. Antibody neutralization and escape by HIV-1.
    Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM.
    Nature; 2003 Mar 20; 422(6929):307-12. PubMed ID: 12646921
    [Abstract] [Full Text] [Related]

  • 7. Structural basis for germline antibody recognition of HIV-1 immunogens.
    Scharf L, West AP, Sievers SA, Chen C, Jiang S, Gao H, Gray MD, McGuire AT, Scheid JF, Nussenzweig MC, Stamatatos L, Bjorkman PJ.
    Elife; 2016 Mar 21; 5():. PubMed ID: 26997349
    [Abstract] [Full Text] [Related]

  • 8. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R.
    Biochem J; 2006 Nov 01; 399(3):483-91. PubMed ID: 16827663
    [Abstract] [Full Text] [Related]

  • 9. Targeted deletion in the beta20-beta21 loop of HIV envelope glycoprotein gp120 exposes the CD4 binding site for antibody binding.
    Berkower I, Patel C, Ni Y, Virnik K, Xiang Z, Spadaccini A.
    Virology; 2008 Aug 01; 377(2):330-8. PubMed ID: 18519142
    [Abstract] [Full Text] [Related]

  • 10. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
    Martín J, LaBranche CC, González-Scarano F.
    J Virol; 2001 Apr 01; 75(8):3568-80. PubMed ID: 11264346
    [Abstract] [Full Text] [Related]

  • 11. Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes.
    Martin L, Stricher F, Missé D, Sironi F, Pugnière M, Barthe P, Prado-Gotor R, Freulon I, Magne X, Roumestand C, Ménez A, Lusso P, Veas F, Vita C.
    Nat Biotechnol; 2003 Jan 01; 21(1):71-6. PubMed ID: 12483221
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.
    Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA, Desjardin E, Newman W, Gerard C, Sodroski J.
    Nature; 1996 Nov 14; 384(6605):179-83. PubMed ID: 8906795
    [Abstract] [Full Text] [Related]

  • 14. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.
    Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, Rudd PM, Dwek RA, Stanfield RL, Burton DR, Wilson IA.
    Science; 2001 Aug 10; 293(5532):1155-9. PubMed ID: 11498595
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.